Advertisement

Related Videos

Matthew Seymour, MD: A Clinical Trialist’s Perspective

Robin Feldman, JD: Are Dubious Patents a Large or Small Issue?

Deborah Collyar: What's In It for Patients?

Cody Peer, PhD, on Simulating Alternative Schedules for Checkpoint Inhibitors

S. Vincent Rajkumar, MD, on Cost-Effective Treatment of Multiple Myeloma

Advertisement

Advertisement




Aug
20
Today In Oncology
Chemotherapy, Immunotherapy, and Targeted Therapy in Advanced, Refractory Malignancies
Mosunetuzumab With Response-Adapted Therapy in Previously Untreated NHL
Study Supports Personalized Weight-Loss Intervention for Breast Cancer Survivors
Digital Integrative Medicine Program Improves Overall Survival in Patients Undergoing Systemic Cancer Treatment
County-Level Medical Debt Linked to Advanced-Stage Cancers, Worse Survival Among Newly Diagnosed U.S. Adults
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo